Log in to save to my catalogue

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fdc6f9b051654ba7a85031b3b9208156

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

About this item

Full title

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

Publisher

London, England: SAGE Publications

Journal title

Therapeutic Advances in Endocrinology and Metabolism, 2022, Vol.13, p.20420188221113140-20420188221113140

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Polycystic ovary syndrome (PCOS) is the most common endocrine condition affecting women. It has traditionally been viewed as a primarily reproductive disorder; however, it is increasingly recognized as a lifelong metabolic disease. Women with PCOS are at increased risk of insulin resistance (IR), type 2 diabetes mellitus, non-alcoholic fatty liver...

Alternative Titles

Full title

Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fdc6f9b051654ba7a85031b3b9208156

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fdc6f9b051654ba7a85031b3b9208156

Other Identifiers

ISSN

2042-0188

E-ISSN

2042-0196

DOI

10.1177/20420188221113140

How to access this item